Simultaneous testing (for colorectal cancer and pancreatic cancer) with a single blood draw! Let's check your current risk before any symptoms appear.
The "Protokey Cancer Risk Test" measures peptides in the blood that have shown changes in cancer patients, evaluating the current risks of colorectal cancer and pancreatic cancer. The current risks of colorectal cancer and pancreatic cancer are assessed on a three-tier scale. By understanding your current cancer risk, you can identify appropriate measures such as lifestyle improvements and undergoing detailed examinations. 【Features】 ■ Blood test only ■ No prior preparation required ■ Short duration *For more details, please download the PDF or feel free to contact us.
Inquire About This Product
basic information
【People like this are receiving it】 ■ Concerns about lifestyle habits: lack of exercise, smoking, tendency to be overweight, insufficient vegetables, drinking habits, frequent consumption of processed meats ■ Concerns about health checkup content: feeling anxious with just the usual checkup, not having undergone a stool occult blood test, having had abnormalities in past tests but leaving them unattended *For more details, please download the PDF or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please download the PDF or feel free to contact us.
catalog（1）
Download All Catalogs
Company information
Our company provides services for disease prevention (Protokey testing) and treatment (receptor-targeted drugs) based on human peptide research. "Protokey testing" is an examination that uses blood bio-marker peptides discovered through our proprietary BLOTCHIP-MS method to assess the risk of various diseases. We conduct biomarker exploration research in collaboration with many universities in Japan and analyze a variety of diseases. Additionally, we offer contract services such as "peptide marker exploration," which involves searching for peptides that could serve as new biomarkers.